Miniatura

Fitxers

rccm.202205-0845oc.pdf (1.47 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2023-06-01

Llicència de publicació

cc by-nc-nd (c) Oldham, Justin M. et al, 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/201427

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1164/rccm.202205-0845OC

Resum

Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by limited treatment options and high mortality. A better understanding of the molecular drivers of IPF progression is needed. Objectives: To identify and validate molecular determinants of IPF survival. Methods: A staged genome-wide association study was performed using paired genomic and survival data. Stage I cases were drawn from centers across the United States and Europe and stage II cases from Vanderbilt University. Cox proportional hazards regression was used to identify gene variants associated with differential transplantation-free survival (TFS). Stage I variants with nominal significance (P < 5 x 10(-5)) were advanced for stage II testing and meta-analyzed to identify those reaching genome-wide significance (P < 5 x 10(-8)). Downstream analyses were performed for genes and proteins associated with variants reaching genome-wide significance. Measurements and Main Results: After quality controls, 1,481 stage I cases and 397 stage II cases were included in the analysis. After filtering, 9,075,629 variants were tested in stage I, with 158 meeting advancement criteria. Four variants associated with TFS with consistent effect direction were identified in stage II, including one in an intron of PCSK6 (proprotein convertase subtilisin/kexin type 6) reaching genome-wide significance (hazard ratio, 4.11 [95% confidence interval, 2.54-6.67]; P = 9.45 x 10(-9)). PCSK6 protein was highly expressed in IPF lung parenchyma. PCSK6 lung staining intensity, peripheral blood gene expression, and plasma concentration were associated with reduced TFS. Conclusions: We identified four novel variants associated with IPF survival, including one in PCSK6 that reached genome-wide significance. Downstream analyses suggested that PCSK6 protein plays a potentially important role in IPF progression.

Matèries

Fibrosi pulmonar, Genètica

Matèries (anglès)

Pulmonary fibrosis, Genetics

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

OLDHAM, Justin m., ALLEN, Richard j., LORENZO SALAZAR, Jose m., MOLYNEAUX, Philip l., MA, Shwu-fan, JOSEPH, Chitra, KIM, John s., GUILLÉN GUIÓ, Beatriz, HERNÁNDEZ BEEFTINK, Tamara, KROPSKI, Jonathan a., HUANG, Yong, LEE, Cathryn t., ADEGUNSOYE, Ayodeji, PUGASHETTI, Janelle vu, LINDERHOLM, Angela l., VO, Vivian, STREK, Mary e., JOU, Jonathan, MUÑOZ BARRERA, Adrian, RUBIO RODRÍGUEZ, Luis a., HUBBARD, Richard, HIRANI, Nik, WHYTE, Moira k. b., HART, Simon, NICHOLSON, Andrew g., LANCASTER, Lisa, PARFREY, Helen, RASSL, Doris, WALLACE, William, VALENZI, Eleanor, ZHANG, Yingze, MYCHALECKYJ, Josyf, STOCKWELL, Amy, KAMINSKI, Naftali, WOLTERS, Paul j., MOLINA MOLINA, María, BANOVICH, Nicholas e., FAHY, William a., MARTÍNEZ, Fernando j., HALL, Ian p., TOBIN, Martin d., MAHER, Toby m., BLACKWELL, Timothy s., YASPAN, Brian l., JENKINS, R. gisli, FLORES, Carlos, WAIN, Louise v., NOTH, Imre. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. _American Journal of Respiratory and Critical Care Medicine_. 2023. Vol. 207, núm. 11, pàgs. 1515-1524. [consulta: 21 de gener de 2026]. ISSN: 1535-4970. [Disponible a: https://hdl.handle.net/2445/201427]

Exportar metadades

JSON - METS

Compartir registre